Chen Medical Associates P A is categorized under Internal Medicine Doctors in Miami, FL and active since 1986.
Chen Medical Associates P A was established in 1986, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact James Chen at the company’s headquarters by writing to 1000 Park Center Boulevard # 100, Miami, Florida FL 33169 or by phoning (305) 653-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chen Medical Associates P A |
| Contact Person: | James Chen |
| Address: | 1000 Park Center Boulevard # 100, Miami, Florida 33169 |
| Phone Number: | (305) 653-5100 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1986 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Chen Medical Associates P A was started in 1986 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact James Chen for inquiries that concern Chen Medical Associates P A by calling the company number (305) 653-5100, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Chen Medical Associates P A can be found at the coordinates 25.929029,-80.219477 as well as the street address 1000 Park Center Boulevard # 100 in Miami, Florida 33169.
For its online presence, you may visit Chen Medical Associates P A’s website at and engage with its social media outlets through on Twitter and on Facebook.